表紙
市場調查報告書

自動注射器的全球市場

Autoinjectors

出版商 Global Industry Analysts, Inc. 商品編碼 893773
出版日期 內容資訊 英文 159 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
自動注射器的全球市場 Autoinjectors
出版日期: 2019年07月01日內容資訊: 英文 159 Pages
簡介

本報告提供全球自動注射器市場相關調查分析,市場概要,主要企業,市場趨勢、促進因素,全球市場預測,各地區市場分析,競爭情形相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢、促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他的歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他的亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • UAE
    • 其他中東
    • 非洲

第4章 競爭

  • ABBVIE
  • ANTARES PHARMA, INC.
  • CONSORT MEDICAL PLC
  • ELI LILLY AND COMPANY
  • HASELMEIER GMBH
  • MYLAN NV
  • OWEN MUMFORD
  • SHL GROUP
  • TEVA PHARMACEUTICAL INDUSTRIES
  • YPSOMED AG

第5章 相關調查

目錄
Product Code: MCP10421

Autoinjectors market worldwide is projected to grow by US$87.9 Billion, guided by a compounded growth of 22.5%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the potential to grow at over 23.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$40.7 Billion by the year 2025, Rheumatoid Arthritis will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 18.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3 Billion to the region's size and clout in the next 5 to 6 years. Over US$3.7 Billion worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Rheumatoid Arthritis will reach a market size of US$1.7 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 31.8% over the next couple of years and add approximately US$27.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, AbbVie, Inc. (USA); Amgen, Inc. (USA); Antares Pharma, Inc. (USA); Becton, Dickinson and Company (USA); Consort Medical PLC (United Kingdom); Eli Lilly and Company (USA); Haselmeier GmbH (Germany); Mylan NV (United Kingdom); Owen Mumford Ltd. (United Kingdom); SHL Group (Taiwan); Teva Pharmaceutical Industries Ltd. (Israel); Ypsomed AG (Switzerland)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Rapid Shift from Self-Injectors to Autoinjectors for Easy and Safe Administration of Drugs Drives Demand
  • North America: The Largest Market for Autoinjectors
  • Global Competitor Market Shares
    • Autoinjectors Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Global Epinephrine Autoinjector market: Percentage Breakdown of Volume Sales by Leading Players for the Year 2019E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Prevalence of Targeted Therapies such as Cancer, Rheumatoid Arthritis, Multiple Sclerosis and Diabetes: A Strong Growth Driver
    • Number of New Cases of Cancer Worldwide for the Years 2012, 2015, 2020, 2025 and 2030
    • Diabetes Prevalence in the Age-Group of 20-79 Years in Millions by Region for the Years 2018, 2021 and 2025
    • Global Injectable Drug Delivery Market: Revenues in US$ Billion for the Years 2016, 2018, 2020, 2022 and 2024
  • Rising Incidence of Anaphylaxis and Increased Prescription Rate of Epinephrine Autoinjectors Boosts Market Demand
  • Increasing Number of Regulatory Approvals for Autoinjectors in Various Diseases
  • Generic Autoinjectors Take Center Stage
    • Patent Expiry of Biologics to Drive the Demand for Biosimilars
  • Strong Government Support and Favorable Reimbursement Policies Propel Market Growth
  • Challenges
    • Development of Autoinjectors for Multiple Drug Viscosities: A Major Challenge
    • Increasing Demand for Alternative Drug Delivery Modes Hampers Market Growth
    • Emergence of Oral Diabetic Agents, Oral Insulin and Epinephrine Nasal Sprays Poses Huge Challenge for Autoinjectors Market
  • Product Overview
    • Autoinjector: Definition

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Autoinjectors Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Autoinjectors Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Autoinjectors Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Rheumatoid Arthritis (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Rheumatoid Arthritis (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Rheumatoid Arthritis (Therapy) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Multiple Sclerosis (Therapy) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Multiple Sclerosis (Therapy) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Multiple Sclerosis (Therapy) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Anaphylaxis (Therapy) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Anaphylaxis (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Anaphylaxis (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Diabetes (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Diabetes (Therapy) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Diabetes (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Other Therapies (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Other Therapies (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Other Therapies (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
    • US Autoinjectors Market Share (in %) by Company: 2019 & 2025
  • TABLE 19: United States Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
  • TABLE 20: Autoinjectors Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017
  • TABLE 21: United States Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

CANADA

  • TABLE 22: Canadian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
  • TABLE 23: Canadian Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017
  • TABLE 24: Autoinjectors Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

JAPAN

  • TABLE 25: Japanese Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025
  • TABLE 26: Autoinjectors Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
  • TABLE 27: Japanese Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

CHINA

  • TABLE 28: Chinese Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
  • TABLE 29: Autoinjectors Historic Market Analysis in China in US$ Million by Therapy: 2009-2017
  • TABLE 30: Chinese Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

  • Market Facts & Figures
    • European Autoinjectors Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • TABLE 31: European Autoinjectors Market Demand Scenario in US$ Million by Region/Country: 2018-2025
  • TABLE 32: Autoinjectors Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
  • TABLE 33: European Autoinjectors Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: European Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
  • TABLE 35: Autoinjectors Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
  • TABLE 36: European Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

FRANCE

  • TABLE 37: Autoinjectors Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
  • TABLE 38: French Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017
  • TABLE 39: French Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

GERMANY

  • TABLE 40: Autoinjectors Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 41: German Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 42: German Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ITALY

  • TABLE 43: Italian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
  • TABLE 44: Autoinjectors Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017
  • TABLE 45: Italian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

  • TABLE 46: United Kingdom Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025
  • TABLE 47: Autoinjectors Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
  • TABLE 48: United Kingdom Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

SPAIN

  • TABLE 49: Spanish Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
  • TABLE 50: Spanish Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017
  • TABLE 51: Autoinjectors Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

RUSSIA

  • TABLE 52: Russian Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
  • TABLE 53: Autoinjectors Market in Russia by Therapy: A Historic Review in US$ Million for 2009-2017
  • TABLE 54: Russian Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF EUROPE

  • TABLE 55: Rest of Europe Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
  • TABLE 56: Autoinjectors Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
  • TABLE 57: Rest of Europe Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ASIA-PACIFIC

  • TABLE 58: Asia-Pacific Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 59: Autoinjectors Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
  • TABLE 60: Asia-Pacific Autoinjectors Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 61: Autoinjectors Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
  • TABLE 62: Asia-Pacific Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017
  • TABLE 63: Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

AUSTRALIA

  • TABLE 64: Autoinjectors Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 65: Australian Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 66: Australian Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

INDIA

  • TABLE 67: Indian Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
  • TABLE 68: Indian Autoinjectors Historic Market Review by Therapy in US$ Million: 2009-2017
  • TABLE 69: Autoinjectors Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

SOUTH KOREA

  • TABLE 70: Autoinjectors Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 71: South Korean Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 72: Autoinjectors Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

  • TABLE 73: Rest of Asia-Pacific Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025
  • TABLE 74: Autoinjectors Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
  • TABLE 75: Rest of Asia-Pacific Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

LATIN AMERICA

  • TABLE 76: Latin American Autoinjectors Market Trends by Region/Country in US$ Million: 2018-2025
  • TABLE 77: Autoinjectors Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
  • TABLE 78: Latin American Autoinjectors Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
  • TABLE 79: Latin American Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
  • TABLE 80: Autoinjectors Historic Market Analysis in Latin America in US$ Million by Therapy: 2009-2017
  • TABLE 81: Latin American Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

  • TABLE 82: Argentinean Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
  • TABLE 83: Autoinjectors Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2009-2017
  • TABLE 84: Argentinean Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

BRAZIL

  • TABLE 85: Autoinjectors Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
  • TABLE 86: Brazilian Autoinjectors Historic Market Scenario in US$ Million by Therapy: 2009-2017
  • TABLE 87: Brazilian Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

MEXICO

  • TABLE 88: Autoinjectors Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 89: Mexican Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 90: Mexican Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

  • TABLE 91: Rest of Latin America Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
  • TABLE 92: Autoinjectors Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2009-2017
  • TABLE 93: Rest of Latin America Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

MIDDLE EAST

  • TABLE 94: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 95: Autoinjectors Market in the Middle East by Region/Country in US$ Million: 2009-2017
  • TABLE 96: The Middle East Autoinjectors Market Share Breakdown by Region/Country: 2009, 2019, and 2025
  • TABLE 97: The Middle East Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
  • TABLE 98: The Middle East Autoinjectors Historic Market by Therapy in US$ Million: 2009-2017
  • TABLE 99: Autoinjectors Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

IRAN

  • TABLE 100: Iranian Market for Autoinjectors: Annual Sales Estimates and Projections in US$ Million by Therapy for the period 2018-2025
  • TABLE 101: Autoinjectors Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
  • TABLE 102: Iranian Autoinjectors Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

ISRAEL

  • TABLE 103: Israeli Autoinjectors Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
  • TABLE 104: Autoinjectors Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2009-2017
  • TABLE 105: Israeli Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

SAUDI ARABIA

  • TABLE 106: Saudi Arabian Autoinjectors Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
  • TABLE 107: Autoinjectors Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2009-2017
  • TABLE 108: Saudi Arabian Autoinjectors Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

  • TABLE 109: Autoinjectors Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 110: United Arab Emirates Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 111: Autoinjectors Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

  • TABLE 112: Autoinjectors Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
  • TABLE 113: Rest of Middle East Autoinjectors Historic Market Analysis in US$ Million by Therapy: 2009-2017
  • TABLE 114: Rest of Middle East Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

AFRICA

  • TABLE 115: African Autoinjectors Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
  • TABLE 116: Autoinjectors Market in Africa by Therapy: A Historic Review in US$ Million for 2009-2017
  • TABLE 117: African Autoinjectors Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBVIE
  • ANTARES PHARMA, INC.
  • CONSORT MEDICAL PLC
  • ELI LILLY AND COMPANY
  • HASELMEIER GMBH
  • MYLAN NV
  • OWEN MUMFORD
  • SHL GROUP
  • TEVA PHARMACEUTICAL INDUSTRIES
  • YPSOMED AG

V. CURATED RESEARCH

Back to Top